Çocuklarda İdiopatik İntrakranial Hipertansiyon ( Psödotümör Serebri)

Year 2020, Volume: 3 Issue: 3, 46 - 53, 31.12.2020

Abdullah Beyoğlu Ali Meşen

Abstract

Psödotümör serebri (PTS), nedeni bilinmeyen intrakraniyal basınç artışıdır. Tanısı modifiye edilmiş Dandy kriterleri ile konulur. Hastalığın semptomları görülme sıklığına göre, artmış kafa içi basıncı nedeniyle baş ağrısı, geçici görme kaybı, bulanık görme ve diplopi şeklinde sıralanabilir. Çocukluk çağı PTS leri yetişkinlere göre farklılık gösterebilmektedir. Görüntüleme yöntemleri tanı konulması için yapılacak olan lumbal poknsiyon (LP) öncesi elzemdir. Bu çalışmada literatürdeki çocukluk çağı PTS leri değerlendirilmiştir.

Keywords

Psödotümör serebri, çocukluk çağı, lumbal poksiyon

References

• 1. Albakr A, Hamad MH, Alwadei AH, Bashiri FA, Hassan HH, Idris H, at al. Idiopathic intracranial hypertension in children: Diagnostic and management approach. Sudanese Journal of Pediatrics 2016;16(2): 67-76.
• 2. Ko MW, Liu GT. Pediatric Idiopathic Intracranial Hypertension (Pseudotumor Cerebri). Horm Res Paediatr 2010;74(6): 381–9.
• 3. Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol 2004;24(2): 138-45.
• 4. Kesler A, Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J Neuroophthalmol 2001;21(1): 12-4.
• 5. Friedman DI. Papilledema and pseudotumor cerebri. Ophthalmol Clin North Am 2001;14(1): 129–47.
• 6. Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: A case-control study in a headache center. Neurology 1998;51(1):245-9.
• 7. Derici Ş, Beckmann Y, Şeçil Y, Yemenicioğlu D, Başoğlu M. Normal Pressure Pseudotumor Cerebri. Türk Nöroloji Dergisi 2008;14(6): 415-8.
• 8. Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci 1997;24(3): 219–21.
• 9. Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999;127(2): 178–82.
• 10. Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45(239): 13–23.
• 11. Rangwala LM, Liu GT: Pediatric idiopathic intracranial hypertension. Surv Ophthalmol 2007;52(6): 597–617.
• 12. Balcer LJ, Liu GT, Forman S, Pun K, Volpe NJ, Galetta SL, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology 1999;52(4): 870– 2.
• 13. Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol 1994;9(2): 144–9.
• 14. Soler D, Cox T, Bullock P, Calver DM, Robinson RO. Diagnosis and management of benign intracranial hypertension. Arch Dis Child 1998;78(1): 89–94.
• 15. Phillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. J AAPOS 1998;2(1): 33–8.
• 16. Lim M, Kurian M, Penn A, Calver D, Lin JP. Visual failure without headache in idiopathic intracranial hypertension. Arch Dis Child 2005;90: 206–10.
• 17. Aylward SC, Waslo CS, Au JN, Tanne E. Manifestations of Pediatric Intracranial Hypertension From the Intracranial Hypertension Registry. Pediatr Neurol 2016;61: 76-82.
• 18. Aylward SC, Reem RE. Pediatric Intracranial Hypertension. Pediatr Neurol 2017;66:32-43.
• 19. Salman MS, Kirkham FJ, MacGregor DL. Idiopathic ‘benign’ intracranial hypertension: case series and review. J Child Neurol 2001;16(7): 465–70.
• 20. Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol 2002;17(10): 745–8.
• 21. Youroukos S, Psychou F, Fryssiras S, Paikos P, Nicolaidou P. Idiopathic intracranial hypertension in children. J Child Neurol 2000;15(7): 453–7.
• 22. Krishna R, Kosmorsky GS, Wright KW. Pseudotumor cerebri sine papilledema with unilateral sixth nerve palsy. J Neuroophthalmol 1998;18(1): 53–5.
• 23. Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996;46(1): 198–202.
• 24. Kanagalingam S, Subramanian PS. Cerebral venous sinus stenting for pseudotumor cerebri: A review. Saudi Journal of Ophthalmology 2015;29(1): 3-8.
• 25. Scoffings DJ, Pickard JD, Higgins JNP. Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2007;78(8): 911-2.
• 26. Said RR, Rosman NP. A negative cranial computed tomographic scan is not adequate to support a diagnosis of pseudotumor cerebri. J Child Neurol 2004;19(8): 609–13.
• 27. Ozsvath RR, Casey SO, Lustrin ES, Alberico RA, Hassankhani A, Patel M. Cerebral venography: comparison of CT and MR projection venography. Ajr 1997;169(6): 1699–707.
• 28. Avery RH, Shah SS, Licht DJ, Seiden JA, Huh JW, Boswinkel J, et al. Reference range of cerebrospinal fluid opening pressure in children undergoing diagnostic lumbar puncture. N Engl J Med 2010;363: 891–3.
• 29. Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105(12): 2313–7.
• 30. Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol 1994;9(2): 130–4.
• 31. Finsterer J, Földy D, Fertl E, Rudolfstiftung K. Topiramate resolves headache from pseudotumor cerebri. J Pain Symptom Manage 2006;32(5): 401–2.
• 32. Thompson PJ, Baxendale SA, Duncan JS, Sander JW. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000;69(5): 636–41.
• 33. Friedman DI, Rausch EA. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002;58(10): 1551–3.
• 34. Mathew NT, Ravishankar K, Sanin LC: Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 1996;46(5): 1226–30.
• 35. VanderVeen DK, Nihalani BR, Barron P, Anderson RL. Optic nerve sheath fenestration for an isolated optic nerve glioma. Jaapos 2009;13(1): 88-90.
• 36. Lee AG, Patrinely JR, Edmond JC. Optic nerve sheath decompression in pediatric pseudotumor cerebri. Ophthalmic Surg Lasers 1998;29(6): 514–7.
• 37. Rekate HL, Wallace D. Lumboperitoneal shunts in children. Pediatr Neurosurg 2003;38(1): 41–6.
• 38. Chumas PD, Kulkarni AV, Drake JM, Hoffman HJ, Humphreys RP, Rutka JT. Lumboperitoneal shunting: a retrospective study in the pediatric population. Neurosurgery 1993;32(3): 376–83.
• 39. Eggenberger ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996;46(6): 1524–30.
• 40. Rosenberg ML, Corbett JJ, Smith C, Goodwin J, Sergott R, Savino P, et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993;43(6): 1071–2.
• 41. Bynke G, Zemack G, Bynke H, Romner B. Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology 2004;63(7): 1314–6.
• 42. Stiebel-Kalish H, Kalish Y, Lusky M, Gaton DD, Ehrlich R, Shuper A. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension. Am J Ophthalmol 2006;142(2): 279–83.
• 43. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology 2004;63(9): 1737–9.